NDC 0615-8331

Senexon-S

Docusate Sodium 50mg And Sennosides 8.6mg

Senexon-S is a Oral Tablet, Film Coated in the Human Otc Drug category. It is labeled and distributed by Ncs Healthcare Of Ky, Inc Dba Vangard Labs. The primary component is Sennosides; Docusate Sodium.

Product ID0615-8331_128157c7-2cc8-4ad9-af8b-51124d325950
NDC0615-8331
Product TypeHuman Otc Drug
Proprietary NameSenexon-S
Generic NameDocusate Sodium 50mg And Sennosides 8.6mg
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2019-10-02
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart334
Labeler NameNCS HealthCare of KY, Inc dba Vangard Labs
Substance NameSENNOSIDES; DOCUSATE SODIUM
Active Ingredient Strength9 mg/1; mg/1
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0615-8331-39

30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8331-39)
Marketing Start Date2020-01-07
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0615-8331-39 [00615833139]

Senexon-S TABLET, FILM COATED
Marketing CategoryOTC MONOGRAPH NOT FINAL
Application Numberpart334
Product TypeHUMAN OTC DRUG
Marketing Start Date2020-01-07

Drug Details

Active Ingredients

IngredientStrength
SENNOSIDES8.6 mg/1

NDC Crossover Matching brand name "Senexon-S" or generic name "Docusate Sodium 50mg And Sennosides 8.6mg"

NDCBrand NameGeneric Name
0536-1247Senexon-SDocusate Sodium 50mg and Sennosides 8.6mg
0536-4086SENEXON-SDOCUSATE SODIUM -SENNOSIDES
0615-7773SENEXON-Sdocusate sodium-sennosides tablet
0615-8083SENEXON-SDOCUSATE SODIUM -SENNOSIDES
0615-8331Senexon-SDocusate Sodium 50mg and Sennosides 8.6mg
33261-749SENEXON-SDOCUSATE SODIUM -SENNOSIDES
52959-675SENEXON-SDOCUSATE SODIUM -SENNOSIDES
68788-9407SENEXON-SDOCUSATE SODIUM -SENNOSIDES
43063-958Docusate Sodium With SennosidesDocusate Sodium 50mg and Sennosides 8.6mg

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.